Archford Capital Strategies »

Alnylam Pharmaceuticals shares owned by Archford Capital Strategies

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Archford Capital Strategies from 13F filings

Historical chart of Archford Capital Strategies investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Archford Capital Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Archford Capital Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $923k 2.0k 456.00
2025-06-30 $658k 2.0k 326.09
2025-03-31 $545k 2.0k 270.02
2022-12-31 $247k 1.0k 237.65
2022-09-30 $209k 1.0k 200.19

More positions owned by Archford Capital Strategies

Ishares Tr Core Msci Eafe (IEFA)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Core Msci Emkt (IEMG)
Spdr Series Trust Portfolio S&p500 (SPLG)
Vanguard Index Fds Growth Etf (VUG)
Visa Com Cl A (V)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Harbor Etf Trust Panagora Dynamic (INFO)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Fundamental Us L (FNDX)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Columbia Etf Tr I Resh Enhnc Cor (RECS)
Broadcom (AVGO)

View all positions for Archford Capital Strategies

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals